Actinium Pharmaceuticals, Inc.
ATNM
$1.24
$0.010.81%
AMEX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 27.90M | -5.52M | -5.94M | -5.13M | -6.88M |
| Total Depreciation and Amortization | 241.00K | 220.00K | 206.00K | 206.00K | 204.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -34.88M | 11.00K | 10.00K | 109.00K | 197.00K |
| Change in Net Operating Assets | 1.56M | -579.00K | 435.00K | -1.51M | 1.09M |
| Cash from Operations | -5.18M | -5.87M | -5.29M | -6.33M | -5.39M |
| Capital Expenditure | -478.00K | -2.00K | -104.00K | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -478.00K | -2.00K | -104.00K | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.00K | -3.00K | -3.00K | -2.00K | -3.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | 0.00 | -207.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -2.00K | -3.00K | -3.00K | -209.00K | -3.00K |
| Foreign Exchange rate Adjustments | 2.00K | 11.00K | 6.00K | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.66M | -5.86M | -5.39M | -6.53M | -5.40M |